Disease Intelligence

As part of its Infectious Disease Analytics (IDA) solution, Airfinity offers more comprehensive analysis of disease burden and its interaction with market indicators via bi-annual disease-specific intelligence reports and briefings, as well as email alerts.

Along with high-level summaries of answers to key questions in the area, you can expect detailed analysis across:

Disease Burden: Global, regional and country-level disease burden forecasts and estimates of true incidence, including demographic breakdowns.

Pipeline: Overview of the development landscape, assessments of candidates in the pipeline, estimated approval dates, and latest efficacy results.

Commercial: Projected market segmentation and funding landscape, growth and size, including forecasted demand scenarios.

Fill out the form and tell us which disease areas you’re interested in. A member of the team will be in touch with more information about how to subscribe and access the reports.

Get In Touch!

We’ll need a few short details about you and your business.

Get In Touch!

We’ll need a few short details about you and your business.

What our users say?


“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force


“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”

Director General,

the economist

“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”

James Fransham, Data Journalist,
The Economist